Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders
Latest Information Update: 21 Jun 2023
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Neuromyelitis optica
- Focus Therapeutic Use
Most Recent Events
- 21 Jun 2023 New trial record